Local residents celebrate China's national day.
VCG VCG via Getty Images
By Clay Chandler
November 28, 2018

Good morning from Guangzhou, China, where, in just a few hours we’ll kick off the Fortune Global Tech Forum, two days of star-studded discussion about how technology is transforming our world. We’ll deep-dive into all the favorite Fourth Industrial Revolution topics: Big Data, the Internet of Things, artificial intelligence, smart cities, and advances in industrial robotics. China’s rise as a technology and innovation superpower will be a recurring theme: Fortune president Alan Murray will referee a lively session entitled “Escaping Thucydides” focusing on U.S.-China tech tensions. Fortune editor-in-chief Clifton Leaf will moderate another pondering the fate of globalization. Adam, as always, will be everywhere, while I’ll lead conversations with Neil Shen, the “King Midas” of China Tech investing; former Google China boss and Sinovation Ventures founder Kai-Fu Lee; Salesforce A.I. guru Richard Socher; and Imperial College management expert George Yip on the subject of “Innovation with Chinese characteristics.”

We convene days ahead of a high-profile dinner meeting in Buenos Aires between Donald Trump and Xi Jinping, where the subject of China’s rise will also top the agenda. In recent weeks, markets have careened wildly on speculation about whether the leaders of the world’s two largest economies will call off their trade war ahead of a January 1 deadline when Trump has threatened to clobber Chinese imports with a new round of tariffs. The outlook isn’t encouraging. Don’t miss this rollicking Trump interview on China by my old Wall Street Journal colleague Bob Davis in which Trump declares it “highly unlikely” that he and Xi will agree. (The full transcript is worth reading—and raises troubling questions about Trump’s grasp of trade and tech issues.)

Meanwhile the week’s biggest China tech story was in the health sector. A Chinese researcher named He Jiankui claims to have produced the world’s first genetically edited babies. Working out of a Shenzhen hospital, He used CRISPR, a powerful new tool for altering genes in human embryos, to rewrite the DNA of two twin girls to make them—he claims—resistant to H.I.V. That might seem like a good thing, but it provoked outrage among medical researchers globally and inside China. Critics called He’s experiment reckless because rewriting the DNA of living humans risks unintended consequences—such as creating greater susceptibility to other illnesses, and passing those genetic weaknesses on to a broader population. The announcement was a shocker: it was made on YouTube, not in a refereed medical journal; He turns out to be a physicist, not a physician; it’s unclear that he obtained informed consent from the girls’ parents or was under any kind of supervision in the facility where he worked. Strangest of all: He’s experiment doesn’t appear to have violated any Chinese laws.

The arc of the gene-editing story, though, is a familiar one in Chinese tech. In China these days, innovation and technological breakthroughs often outpace the ability of the government to create legal and institutional frameworks to regulate it. In sectors as varied as bike-sharing, ride-hailing, financial services and online gaming, the pattern in China is for technology to spiral unrestricted until, inevitably, someone gets hurt—provoking Beijing to crack down and regulate the sector with a vengeance. For a great case study of exactly that cycle, I recommend this outstanding analysis published yesterday in The Information examining how Beijing slammed the brakes on reckless expansion at Didi Chuxing, the world’s largest on-demand transportation company. All the more reason to be talking about technology tomorrow in Guangzhou!

A version of this article appeared in the November 28 edition of Fortune’s Data Sheet newsletter.

SPONSORED FINANCIAL CONTENT

You May Like

EDIT POST